Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7487

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907487)

Label Image (Lbl500907487)
Rosuvastatin Calcium 10 mg film-coated tablets carton label from A-S Medication Solutions. The label displays product NDC 50090-7487-0 and specifies storage at 68 to 77 degrees Fahrenheit, protecting from moisture. The package contains 90 tablets with oral administration.*
FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)
A line graph comparing cumulative incidence percentages over a 5-year period between Placebo and Rosuva groups. The graph includes a hazard ratio (HR 0.56, 95% CI 0.46 to 0.69) and a significance level (P<0.001). Number at risk counts for each group are provided at multiple timepoints along the x-axis representing years.*
FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)
A forest plot chart comparing the number of cardiovascular-related events between Rosuvastatin Calcium 20 mg and placebo groups. It lists event rates, hazard ratios with 95% confidence intervals, and P values for endpoints including primary composite events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization.*
FDA Label Image

Figure 3. (Rosuvastatin Fig3)

Figure 3. (Rosuvastatin Fig3)
A box plot chart depicting the percent change from baseline in LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. Each statin is shown at multiple dose levels, with values on the vertical axis ranging from 0 to -75 percent change, illustrating the LDL-C lowering effect by dose.*
FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical Structure (Rosuvastatin Str)
Chemical structure of Rosuvastatin Calcium showing its molecular arrangement with a fluorophenyl group, sulfonyl methyl group, and calcium ion complex as depicted in the structural diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.